The effect of PTRF on the prognosis of TMZ-treated GBM patients is independent of the methylation of O6-Methylguanine-DNA Methyltransferase (MGMT) promoter (pMGMT) (Figure 1C-F and Figure S1C-F). Here, MGMT is linked to glioblastoma.